Hard Gelatin Capsules Market

How big is Hard Gelatin Capsules Market in 2026?

Demand is projected to expand at 5.8% CAGR from 2026 to 2036. Market value rises from USD 2.05 billion in 2025 to USD 2.17 billion in 2026 and USD 3.81 billion by 2036.

The hard gelatin capsules market is estimated at USD 2.17 billion in 2026 and is projected to reach USD 3.81 billion by 2036, with demand expanding at a CAGR of 5.8%. Capsule shells support pharmaceutical and nutraceutical products whose formulation and manufacturing requirements vary with the intended use, making consistent shell performance relevant to filling and subsequent product quality. Gelatin’s processing characteristics help support the production of two-piece shells, while the suitability of the finished dosage form depends on the shell, fill material and manufacturing process together. [2] The market therefore includes a range of sizes and designs rather than a single interchangeable container, with suppliers offering options for conventional powder filling, liquid filling and other defined applications. [3] Development services described by Capsugel also connect custom capsule design with oral-solid, lipid-based and inhalation formulations, illustrating the relationship between the shell and the wider dosage-form program. [1] For pharmaceutical users, dissolution and appropriate quality testing remain relevant to finished-product assessment. [4] Growth is consequently expected to follow manufacturing output and formulation needs, supported by reliable gelatin sourcing, compatible filling operations and a clear specification for the intended product.

Key Market Trends & Insights

• Capsule suppliers are extending their offerings across dry powder, liquid-fill and defined inhalation applications, with each format requiring a shell suited to the formulation and process. [1][3]
• Automation and consistent shell dimensions remain relevant to filling performance, because production efficiency depends on reliable handling as well as nominal capsule capacity. [2]
• Pharmaceutical buyers continue to assess finished-product performance through appropriate quality testing, rather than assuming that an established shell material determines the behavior of every formulation. [4]

Regional Highlights

• India’s pharmaceutical manufacturing base supports substantial capsule demand, with local suppliers serving both conventional oral products and more differentiated formulation requirements.
• China’s OTC and self-care market contributes demand for capsule presentations, while pharmaceutical users still require a defined shell and formulation specification.
• Capsugel’s development network includes Colmar in France and Tampa in the United States, illustrating the link between capsule design and formulation-development services in established markets. [1]

Market Size & Forecast

Table 1: Market Size and Forecast for Hard Gelatin Capsules Market (USD billion and percentage), 2025 to 2036

Metric	Value
2025 market value	USD 2.05 billion
2026 market value	USD 2.17 billion
2036 market value	USD 3.81 billion
CAGR 2026 to 2036	5.8%
Revenue increase 2026 to 2036	USD 1.64 billion
Market expansion 2026 to 2036	1.76 times

Demand through 2036 is expected to follow pharmaceutical and supplement production while also reflecting the technical needs of newer formulations. Super generics development can create a requirement for differentiated capsule presentations, although the shell alone does not establish a product’s treatment benefit. Suppliers can address this demand through consistent dimensions, suitable material specifications and application support, helping manufacturers match the capsule with filling equipment and the performance expected from the complete dosage form. [1][2][3][4]

How do material and formulation requirements shape capsule purchasing?

A hard gelatin shell must perform during manufacture and remain compatible with the intended fill, which makes the material specification and application important to procurement. GELITA describes the processing characteristics of gelatin for hard capsules, while ACG distinguishes product variants by use. Finished pharmaceutical products also require appropriate performance testing, so shell selection forms one part of the dosage-form development process. [2][3][4]

Table 2: Industry evidence relevant to the hard gelatin capsules market

Indicator	Data point or observation	Market relevance	Source
Shell material	Gelatin processing characteristics support two-piece hard-capsule manufacture.	Material selection affects manufacturing behavior.	[2]
Application range	ACG offers variants for powder, liquid-fill and inhalation uses.	Capsule choice depends on the formulation and intended application.	[3]
Finished-product quality	FDA provides dissolution-testing guidance for oral dosage forms.	The complete formulation needs appropriate performance assessment.	[4]

Analyst Perspective

"Hard gelatin capsules are anticipated to keep steady use across pharmaceutical and nutraceutical manufacturing as oral dosage programs need reliable shells."

- Anurag Sharma, Principal Analyst at Future Market Insights

How is the Hard Gelatin Capsules Market segmented?

The market is segmented by Source, Size, Route of Administration, End User, and Region.

Source and size define two early choices in capsule development: the gelatin must meet the material requirements of the shell, while available volume needs to accommodate the intended dose and fill properties. Route of administration adds application-specific demands, including the distinction between oral products and inhalation use. End-user coverage spans pharmaceutical manufacturers, nutraceutical producers and development organizations, whose requirements can range from standard shells to formulation assistance. These axes connect directly in production, where source qualification, dimensional consistency and filling compatibility influence the suitability of the selected capsule for the complete dosage form. [1][2][3][4]

Why does the type-b gelatin segment lead demand by source?

The Type-B gelatin segment is projected to account for 46.7% of source demand in 2026.

Table 3: Source Share for Hard Gelatin Capsules Market (percentage share), 2026

Source	Estimated share (2026)
Type-B gelatin	46.7%
Other sources	53.3%
Total	100.0%

Table 4: Segment Position and Market Growth for Hard Gelatin Capsules Market, 2026 to 2036

Metric	Value
Global CAGR (2026 to 2036)	5.8%
Profiled source segment	Type-B gelatin

Type-B gelatin leads the source mix in the market outlook, giving suppliers a substantial requirement for material that can support consistent shell production. The commercial role of the material depends on its suitability for the manufacturing process and the intended formulation, rather than on source identity alone. GELITA describes the processing behavior that makes gelatin useful for hard capsules, including the characteristics needed to form and handle a two-piece shell. [2] Manufacturers also need to consider the specification of the gelatin and the way the finished capsule performs with its fill. These requirements connect sourcing with production consistency, helping explain why qualified material supply remains important when pharmaceutical and nutraceutical producers select a capsule partner.

• Type-B gelatin is projected to represent 46.7% of source demand in 2026, supported by material requirements for consistent formation and handling of two-piece capsule shells. [2]
• Gelatin source and material specifications need to fit the intended product, including the manufacturing process and the requirements attached to the finished dosage form. [2][4]

Why does the size 0 capsules segment lead demand by size?

The Size 0 capsules segment is projected to account for 19.7% of size demand in 2026.

Table 5: Size Share for Hard Gelatin Capsules Market (percentage share), 2026

Size	Estimated share (2026)
Size 0 capsules	19.7%
Other size segments	80.3%
Total	100.0%

Size 0 capsules occupy the leading position within a size category that offers manufacturers several fill-volume options, allowing the shell to be matched to a formulation rather than chosen independently of it. The required size depends on the dose and the physical characteristics of the fill, as well as the process used to manufacture the finished product. ACG’s range illustrates how capsule offerings vary by application, while development services can connect custom shell design with formulation work. [1][3] Manufacturers consequently need to consider available volume alongside handling, filling and the intended route of use. The segment’s position reflects this practical role within common production requirements, without implying that a single size is appropriate for every medicine or supplement.

• Size 0 capsules are projected to hold 19.7% of size demand in 2026, reflecting their fill-volume role within established pharmaceutical and supplement production requirements. [3]
• Capsule size must be considered together with fill properties and the intended dose, because nominal volume alone does not establish formulation suitability. [1][3]

What are the drivers, restraints, and opportunities in the Hard Gelatin Capsules Market?

A qualified capsule shell needs to perform with the actual fill and production equipment, making formulation support and supply consistency commercially relevant alongside shell price. Manufacturers can reduce uncertainty in supplier selection by establishing the intended dose, material specification and filling requirements together, then assessing the finished product through the testing appropriate to its use. [1][2][3][4]

Driver

Pharmaceutical and nutraceutical production sustains recurring demand for shells whose material and dimensions remain consistent through filling and handling. Gelatin supply supports that requirement when the selected grade meets the capsule manufacturer’s processing specification. [2] Finished-product needs then determine the appropriate size and application characteristics, with the shell considered together with its fill. Suppliers able to maintain reliable material quality and suitable production support can address manufacturers’ continuing need for dependable dosage-form output. [1][3][4]

Restraint

Gelatin source, fill compatibility and manufacturing conditions can restrict the suitability of a shell for a particular product, making technical qualification necessary before commercial production. [2][3] Pharmaceutical manufacturers also need to assess the performance of the complete formulation through appropriate testing, rather than treating an empty capsule specification as a substitute for finished-product evidence. [4] These requirements can increase development effort or favor a different shell material where the intended fill or customer specification is not well matched to gelatin.

Opportunity

Capsule filling machines need to operate with the selected shell and fill, creating an opportunity for closer coordination between capsule supply and manufacturing support. [1][3] Suppliers can help manufacturers define the appropriate dimensions and application variant before production, including products involving liquid filling or inhalation. Clear material specifications and formulation assistance then support the assessment of the complete dosage form, giving buyers a practical basis for selecting a shell and testing its performance within the intended process. [2][4]

Which country CAGRs are profiled in the Hard Gelatin Capsules Market?

Table 6: Country CAGR Comparison for Hard Gelatin Capsules Market (CAGR percentage), 2026 to 2036

Country	CAGR	Forecast period
India	6.6%	2026 to 2036
China	5.8%	2026 to 2036
Germany	1.8%	2026 to 2036
France	2.9%	2026 to 2036
United States	1.8%	2026 to 2036

Country-wise Analysis

India Hard Gelatin Capsules Market Outlook (2026 to 2036)

India’s pharmaceutical manufacturing base supports capsule demand across a broad range of oral products, giving local producers an established market for both standard shells and application-specific variants. ACG’s gelatin range includes products intended for conventional use, liquid filling and dry powder inhalation, illustrating the diversity of requirements a capsule supplier may address. [3] India is projected at a CAGR of 6.6% from 2026 to 2036, the highest rate among the five countries profiled here. Manufacturers need to connect this production opportunity with consistent material supply and reliable filling performance, because the commercial value of the shell depends on its role within the complete dosage form. Product qualification therefore remains relevant alongside the scale of pharmaceutical output.

China Hard Gelatin Capsules Market Outlook (2026 to 2036)

China’s OTC and self-care demand contributes to capsule consumption, with the market outlook linking growth to the use of convenient medicine and supplement presentations. The intended consumer product still needs a clear specification for shell material, size and fill compatibility, because a familiar capsule format can contain formulations with different processing needs. Gelatin’s material characteristics support shell manufacture, while application-specific variants address particular fill requirements. [2][3] The Chinese market is projected to record a CAGR of 5.8% from 2026 to 2036. Suppliers serving this demand need to maintain consistency across production runs and ensure that the capsule can be handled by the manufacturer’s equipment, connecting market expansion with dependable commercial production rather than presentation choice alone.

Germany Hard Gelatin Capsules Market Outlook (2026 to 2036)

German demand is associated with established pharmaceutical use and consumer interest in capsule presentations, including the practical importance of administration and taste masking in suitable products. These considerations need to be assessed for the intended formulation and user, since a capsule is not automatically the best presentation for every patient or medicine. The German market is projected at a CAGR of 1.8% from 2026 to 2036. Within this measured expansion, manufacturers can focus on consistent material quality and the fit between shell design, filling operations and finished-product performance. GELITA’s description of hard-capsule gelatin highlights the manufacturing characteristics behind the format, while pharmaceutical performance testing remains a separate requirement for the completed dosage form. [2][4]

France Hard Gelatin Capsules Market Outlook (2026 to 2036)

Capsugel’s Colmar development center gives France a concrete connection between capsule design and formulation services, covering oral-solid, lipid-based liquid-fill and dry powder inhalation programs. [1] This places capsule demand within a development setting where the shell is considered together with the intended formulation and transfer toward manufacturing, rather than purchased solely as a standard container. France is projected to expand at a CAGR of 2.9% from 2026 to 2036. Commercial opportunities can therefore include support for differentiated products as well as continuing supply to established manufacturing programs. Buyers need to assess whether the available design and application expertise addresses their particular dosage-form requirements, while keeping the quality of the finished pharmaceutical product central to qualification and production.

United States Hard Gelatin Capsules Market Outlook (2026 to 2036)

The United States combines established capsule manufacturing demand with formulation-development services, including Capsugel’s Tampa operation for oral-solid and dry powder inhalation drug products. [1] This setting connects shell selection with clinical supply, commercial manufacturing and the quality work needed for the completed product. FDA’s dissolution guidance provides an official reference for relevant oral dosage forms, making product performance a separate consideration from the specification of an empty capsule. [4] A 1.8% CAGR is projected for the United States from 2026 to 2036. Suppliers can address this market through dependable shell supply and application support, particularly where manufacturers need to coordinate fill properties, capsule dimensions and equipment handling within a qualified production process.

Who are the notable companies in the Hard Gelatin Capsules Market?

ACG Worldwide; Capsugel; Qualicaps; Sunil Healthcare Ltd.; Suheung Co., Ltd.

Empty capsule suppliers compete through shell consistency, available sizes and the application assistance needed to match a shell with a workable fill and production process. [2][3] Some manufacturers focus on standard two-piece shells, while others offer additional design or formulation services. Buyers can assess these capabilities against their own development resources, considering material qualification, filling requirements and finished-product testing so that the supplier’s offering addresses the particular dosage form being brought into production. [1][4]

Competitive Benchmarking: Hard Gelatin Capsules Market

Table 7: Competitive positioning for the hard gelatin capsules market

Company	Positioning	Commercial distinction
ACG Worldwide	Gelatin capsule supply and application variants	Offers gelatin capsule options for conventional, liquid-fill and inhalation applications. [3]
Capsugel	Capsule design and dosage-form solutions	Connects capsule development with formulation and manufacturing services. [1]
Qualicaps	Two-piece hard-capsule supply	Produces empty capsule shells for pharmaceutical applications.
Sunil Healthcare Ltd.	Empty hard-capsule manufacturing	Supplies capsules for pharmaceutical and nutraceutical production.
Suheung Co., Ltd.	Capsules and dosage-form manufacturing	Participates in hard-capsule supply through its capsule manufacturing portfolio.

Key Developments in the Hard Gelatin Capsules Market

• Capsugel’s current development network connects custom capsule design in Colmar with oral-solid and inhalation manufacturing services in Tampa, illustrating the integration of shell and formulation expertise. [1]
• ACG’s gelatin capsule portfolio includes application-specific options for liquid filling and dry powder inhalation, showing how suppliers address requirements beyond conventional powder-filled oral products. [3]
• FDA’s final dissolution guidance for specified immediate-release oral products continues to provide a performance-testing reference, reinforcing the distinction between shell selection and assessment of the finished medicine. [4]

Key Players in the Hard Gelatin Capsules Market

Gelatin capsule supply and application variants

• ACG Worldwide

Capsule design and dosage-form solutions

• Capsugel

Two-piece hard-capsule supply

• Qualicaps

Empty hard-capsule manufacturing

• Sunil Healthcare Ltd.

Capsules and dosage-form manufacturing

• Suheung Co., Ltd.

Hard Gelatin Capsules Market - Report Scope

Table 8: Report Scope for Hard Gelatin Capsules Market, 2026 to 2036

Coverage field	Report scope
Market	Hard Gelatin Capsules Market
Historical reference year	2025
Base year	2026
Forecast period	2026 to 2036
Quantitative units	USD billion and percentage shares/CAGRs
2026 market value	USD 2.17 billion
2036 market value	USD 3.81 billion
Forecast CAGR	5.8% from 2026 to 2036
Segmentation	source, size, route of administration, end user
Country profiles	India, China, Germany, France, United States

Hard Gelatin Capsules Market - Research Methodology

Table 9: Research Methodology for Hard Gelatin Capsules Market, 2026 edition

Method	Approach
Market definition	Products, services and commercial applications are separated according to their function and purchasing context.
Secondary research	FMI market coverage is assessed alongside official technical guidance, regulatory material and relevant first-party disclosures.
Segmentation	Demand is organized by the stated category axes, retaining the distinction between segment shares and growth rates.
Country assessment	Local care pathways, purchasing conditions and service availability inform the interpretation of each geographic outlook.
Competitive assessment	Participants are compared by relevant offering, customer setting and delivery capability rather than unsupported company rankings.
Consistency review	Market values, forecast periods, units, segment labels and country growth rates are checked for agreement throughout the analysis.

Hard Gelatin Capsules Market by Segments

Hard Gelatin Capsules Market segmented by Source:

• Type-A gelatin (pork skin)
  • Type-B gelatin (animal bones & calf skin)
  • Fish bone gelatin

Hard Gelatin Capsules Market segmented by Size:

• Size 00 capsules
  • Size 0 capsules
  • Size 1 capsules
  • Size 2 capsules
  • Size 3 capsules
  • Size 4 capsules
  • Size 5 capsules

Hard Gelatin Capsules Market segmented by Route of Administration:

• Oral administration
  • Inhalation

Hard Gelatin Capsules Market segmented by End User:

• Pharmaceutical companies
  • Cosmetic & nutraceutical companies
  • CROs & CDMOs

Hard Gelatin Capsules Market by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• [1] Capsugel. Accessed 15 October 2026. Pharmaceutical CDMO Services
• [2] GELITA. Accessed 15 October 2026. Hard capsules
• [3] ACG. Accessed 15 October 2026. Gelatin capsules
• [4] US Food and Drug Administration. Accessed 15 October 2026. Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances

This Report Answers

• How big is the hard gelatin capsules market in 2026?
• What is the market outlook through 2036?
• Which segments lead demand in 2026?
• Which countries are examined in the forecast?
• Which companies participate in the market?